WHEN IS IT SAFE NOT TO REPLACE AN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR GENERATOR

被引:15
作者
TCHOU, P
AXTELL, K
ANDERSON, AJ
KEIM, S
SRA, J
TROUP, P
JAZAYERI, M
AVITALL, B
AKHTAR, M
机构
[1] UNIV PITTSBURGH,MED CTR,PITTSBURGH,PA 15260
[2] UNIV WISCONSIN,SINAI SAMARITAN MED CTR,MILWAUKEE,WI 53201
来源
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY | 1991年 / 14卷 / 11期
关键词
D O I
10.1111/j.1540-8159.1991.tb02783.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In most reports on patients receiving implantable cardioverter defibrillators, shocks were received mainly during the first 2 to 3 years. Thus, the question had been raised as to the need for device replacement after 3 or 4 years if no shocks had been received. In order to answer this question, shock experience in 184 patients receiving the implantable cardioverter defibrillator was analyzed. Patients were followed for a mean of 24 +/- 18.7 months. A patient's shock was judged to be appropriate if there was electrocardiographic documentation of sustained ventricular tachyarrhythmia at the time of shock or if it was preceded by sudden onset of presyncopal or syncopal symptoms. The majority of patients had coronary artery disease. In approximately two-thirds of patients, left ventricular ejection fraction was below 40%. One hundred fourteen patients had inducible sustained monomorphic ventricular tachycardia. On follow-up, there were 29 deaths, five of which were sudden. Sixty-eight patients received an appropriate shock during follow-up (37%). Over 90% of these 68 received their first shock within the 2 years after implant. The actuarial risk of receiving an appropriate shock by the fifth year after implant was 69%. Conversely, 31% of patients who survived 5 years had not received an appropriate shock. Hazard analysis indicates that there is a high incidence of first appropriate shock during the year following implant. Subsequently, the incidence dropped to a relatively steady rate with a rise in this rate during the fifth year. This analysis suggested a bimodal distribution of appropriate shocks. The results indicate that implantable cardioverter defibrillator generators should be replaced even up to the fifth year despite the fact that a patient had not received an appropriate shock.
引用
收藏
页码:1875 / 1880
页数:6
相关论文
共 13 条
[1]   CLINICAL-EXPERIENCE, COMPLICATIONS, AND SURVIVAL IN 70 PATIENTS WITH THE AUTOMATIC IMPLANTABLE CARDIOVERTER DEFIBRILLATOR [J].
ECHT, DS ;
ARMSTRONG, K ;
SCHMIDT, P ;
OYER, PE ;
STINSON, EB ;
WINKLE, RA .
CIRCULATION, 1985, 71 (02) :289-296
[2]   ACTUARIAL INCIDENCE AND PATTERN OF OCCURRENCE OF SHOCKS FOLLOWING IMPLANTATION OF THE AUTOMATIC IMPLANTABLE CARDIOVERTER DEFIBRILLATOR [J].
FOGOROS, RN ;
ELSON, JJ ;
BONNET, CA .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1989, 12 (09) :1465-1473
[3]   AICD BENEFIT [J].
FURMAN, S .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1989, 12 (03) :399-400
[4]   AUTOMATIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR - PATIENT SURVIVAL, BATTERY LONGEVITY AND SHOCK DELIVERY ANALYSIS [J].
GABRY, MD ;
BRODMAN, R ;
JOHNSTON, D ;
FRAME, R ;
KIM, SG ;
WASPE, LE ;
FISHER, JD ;
FURMAN, S .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 9 (06) :1349-1356
[5]   NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481
[6]  
LEE ET, 1980, STATISTICAL METHODS
[7]   THE AUTOMATIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR - EFFICACY, COMPLICATIONS, AND DEVICE FAILURES [J].
MARCHLINSKI, FE ;
FLORES, BT ;
BUXTON, AE ;
HARGROVE, WC ;
ADDONIZIO, VP ;
STEPHENSON, LW ;
HARKEN, AH ;
DOHERTY, JU ;
GROGAN, EW ;
JOSEPHSON, ME .
ANNALS OF INTERNAL MEDICINE, 1986, 104 (04) :481-488
[8]   MORTALITY IN PATIENTS WITH IMPLANTED AUTOMATIC DEFIBRILLATORS [J].
MIROWSKI, M ;
REID, PR ;
WINKLE, RA ;
MOWER, MM ;
WATKINS, L ;
STINSON, EB ;
GRIFFITH, LSC ;
KALLMAN, CH ;
WEISFELDT, ML .
ANNALS OF INTERNAL MEDICINE, 1983, 98 (05) :585-588
[9]   THE AUTOMATIC IMPLANTABLE DEFIBRILLATOR [J].
MIROWSKI, M ;
MOWER, MM ;
REID, PR .
AMERICAN HEART JOURNAL, 1980, 100 (06) :1089-1092
[10]   AUTOMATIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS AND SURVIVAL OF PATIENTS WITH LEFT-VENTRICULAR DYSFUNCTION AND MALIGNANT VENTRICULAR ARRHYTHMIAS [J].
TCHOU, PJ ;
KADRI, N ;
ANDERSON, J ;
CACERES, JA ;
JAZAYERI, M ;
AKHTAR, M .
ANNALS OF INTERNAL MEDICINE, 1988, 109 (07) :529-534